GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » Retained Earnings

Alto Neuroscience (Alto Neuroscience) Retained Earnings : $-90.38 Mil (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Alto Neuroscience Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Alto Neuroscience's retained earnings for the quarter that ended in Mar. 2024 was $-90.38 Mil.

Alto Neuroscience's quarterly retained earnings declined from Sep. 2023 ($-65.75 Mil) to Dec. 2023 ($-76.97 Mil) and declined from Dec. 2023 ($-76.97 Mil) to Mar. 2024 ($-90.38 Mil).

Alto Neuroscience's annual retained earnings declined from Dec. 2021 ($-12.95 Mil) to Dec. 2022 ($-40.66 Mil) and declined from Dec. 2022 ($-40.66 Mil) to Dec. 2023 ($-76.97 Mil).


Alto Neuroscience Retained Earnings Historical Data

The historical data trend for Alto Neuroscience's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alto Neuroscience Retained Earnings Chart

Alto Neuroscience Annual Data
Trend Dec21 Dec22 Dec23
Retained Earnings
-12.95 -40.66 -76.97

Alto Neuroscience Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Retained Earnings Get a 7-Day Free Trial -40.66 - -65.75 -76.97 -90.38

Alto Neuroscience Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.


Alto Neuroscience  (NYSE:ANRO) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Alto Neuroscience (Alto Neuroscience) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Alto Neuroscience Inc is a clinical stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and highly effective treatment options. the company currently consists of five clinical-stage assets initially targeting major depressive disorder and schizophrenia populations as identified by independent brain-based biomarkers.

Alto Neuroscience (Alto Neuroscience) Headlines

From GuruFocus